When estrogen and progesterone drop to low levels, the effects ripple across nearly every system in a woman’s body. These two hormones do far more than regulate periods. They influence bone strength, heart health, brain function, sleep, skin, mood, and fertility. The specific symptoms and consequences depend on why levels are low, how quickly they dropped, and your age when it happens.
What Low Levels Actually Look Like
The symptoms of low estrogen and progesterone overlap significantly, and most women experience several at once. The most recognizable signs include hot flashes, night sweats, irregular or absent periods, vaginal dryness, and a noticeable drop in sex drive. But the less obvious symptoms are just as common: dry skin, tender breasts, trouble sleeping, difficulty concentrating, irritability, headaches around your period, fatigue, and weight gain concentrated in the belly.
Many women describe the cognitive effects as “brain fog,” a persistent sense that thinking takes more effort than it used to. Estrogen plays a direct role in how the brain produces and uses mood-regulating chemicals like serotonin, so when levels fall, mood changes and anxiety often follow. Progesterone has a calming effect on the nervous system, so losing it compounds the problem. The combination of poor sleep, low mood, and foggy thinking can feel overwhelming, and it helps to know that these symptoms have a clear hormonal explanation.
Why Hormone Levels Drop
The most common reason is the menopause transition. Data from a large U.S. study tracking over 3,300 women ages 40 to 52 shows that estrogen levels hold relatively steady until about two years before the final menstrual period, then decline rapidly. The most intense hormonal changes span roughly four years, centered on that final period. After the last period, measurable progesterone production essentially stops within the first year, while estrogen levels continue to fluctuate briefly before stabilizing at a permanently low baseline about two years later.
But menopause isn’t the only cause. In younger women, low levels of both hormones can result from several conditions. Primary ovarian insufficiency (sometimes called premature ovarian failure) causes the ovaries to stop functioning normally before age 40. Hypothalamic amenorrhea occurs when the brain’s hormonal signaling shuts down, often triggered by extreme stress, very low body weight, or excessive exercise. Eating disorders are a well-documented cause. Certain medical treatments, including chemotherapy and radiation to the pelvic area, can damage the ovaries directly. Surgical removal of the ovaries causes an immediate and dramatic drop in both hormones.
Effects on Bone Health
Estrogen is one of the primary regulators of bone maintenance. When levels fall, the body’s bone-breakdown cells become more numerous and more active while also surviving longer than they normally would. At the same time, the signals that keep bone-building in balance weaken. The net result is that bone is lost faster than it can be replaced.
The mechanism involves the immune system in a way that surprised researchers. Estrogen deficiency triggers certain immune cells in the bone marrow to ramp up production of an inflammatory signal called TNF-alpha, which accelerates the creation and activity of bone-destroying cells. This means the bone loss from low estrogen isn’t just a passive fading. It’s an active inflammatory process. The practical consequence is significant: estrogen deficiency is the primary driver of osteoporosis in postmenopausal women, and the bone loss is fastest in the first few years after menopause, when the hormonal shift is most dramatic.
Heart and Metabolic Risks
Heart disease in women is overwhelmingly a disease of aging, rarely appearing before the sixth decade of life. The timing isn’t coincidental. Estrogen helps maintain the flexibility of blood vessels, supports healthy cholesterol balance, and has anti-inflammatory effects on arterial walls. When estrogen declines after menopause, inflammatory markers associated with plaque buildup in the arteries increase, and the cardiovascular protection women enjoyed during their reproductive years gradually erodes.
The metabolic changes are noticeable too. Many women gain weight during and after the menopause transition even without changes in diet or activity. Fat distribution shifts toward the abdomen, which carries higher metabolic risk than fat stored in the hips and thighs. Insulin sensitivity can also decline, raising the risk of type 2 diabetes.
Fertility and the Role of Progesterone
For women still trying to conceive, low progesterone is particularly consequential. After ovulation, the structure left behind on the ovary (the corpus luteum) produces progesterone, which transforms the uterine lining from a proliferating state into one that can accept and support an embryo. Without adequate progesterone, the lining doesn’t develop properly for implantation, even if an egg has been fertilized.
This condition, called luteal phase deficiency, is defined by insufficient progesterone exposure to maintain the endometrial lining needed for early pregnancy. Interestingly, research has shown that even clearly low progesterone levels can produce a uterine lining that looks completely normal under a microscope, which is one reason this condition has been difficult to diagnose through biopsies alone. Progesterone remains absolutely essential through early pregnancy until the placenta takes over hormone production, typically around weeks 8 to 10. A shortfall during that window can threaten an otherwise viable pregnancy.
How Hormone Levels Are Tested
Timing matters when testing reproductive hormones because levels fluctuate dramatically throughout the menstrual cycle. Research on optimal blood draw timing found that estrogen measurements are most reliable between days 9 and 11 of the cycle (counting from the first day of your period), while progesterone is best assessed between days 17 and 21, when it should be at its peak if ovulation occurred normally. For estrogen specifically, follicular phase levels typically range from 20 to 350 pg/mL, rising to 30 to 450 pg/mL during the luteal phase.
If your periods have already stopped or become highly irregular, the timing constraint becomes less relevant, and your doctor may draw blood on any day. In that case, additional markers like follicle-stimulating hormone (FSH) are often tested alongside estrogen and progesterone. FSH rises significantly when the ovaries stop responding, so a high FSH paired with low estrogen is the classic lab pattern of menopause or ovarian insufficiency.
Treatment Options
Hormone therapy remains the most effective treatment for the vasomotor symptoms of estrogen deficiency, meaning hot flashes, night sweats, and related sleep disruption. For women who have had a hysterectomy, estrogen alone is typically used. For women with an intact uterus, a progestogen must be added to the estrogen. This isn’t optional: estrogen without progesterone stimulates the uterine lining to grow unchecked, raising the risk of endometrial hyperplasia and cancer. The progesterone component counteracts that risk.
For vaginal dryness and related symptoms, low-dose vaginal estrogen is effective and safe, with very little absorption into the rest of the body. It’s generally preferred over systemic hormone therapy when vaginal symptoms are the primary concern. One newer option pairs estrogen with a compound that protects the uterus without requiring a separate progestogen, which some women prefer for its simpler regimen.
Government-approved bioidentical hormones (chemically identical to what the body produces) are considered safe and effective. However, custom-compounded bioidentical hormones, which are mixed by specialty pharmacies rather than manufactured under standard pharmaceutical oversight, lack sufficient evidence for safety and efficacy. Major medical societies do not recommend them as a substitute for regulated products.
Beyond hormone therapy, the downstream consequences of low estrogen and progesterone, particularly bone loss and cardiovascular risk, are managed through weight-bearing exercise, adequate calcium and vitamin D, maintaining a healthy weight, and monitoring bone density over time. For women who cannot or choose not to use hormones, non-hormonal options exist for managing hot flashes and mood symptoms, though they are generally less effective than hormone therapy for severe symptoms.